Dongyang Pharmaceutical said that its self-developed Tokumendong double insulin was approved for marketing to treat type 2 diabetes in adults. Dongyang Pharmaceutical became the second domestic pharmaceutical company to be approved for this type, and the number of insulin approved domestically increased to 7.

Dongyang Pharmaceutical said that its self-developed Tokumendong double insulin was approved for marketing to treat type 2 diabetes in adults. Dongyang Pharmaceutical became the second domestic pharmaceutical company to be approved for this type, and the number of insulin approved domestically increased to 7.